0
The FDA has approved a five-day, once-daily IV and oral 750-mg regimen of levofloxacin (Levaquin drug, Ortho-McNeil, PriCara) for patients with complicated urinary tract infections (UTIs) and acute pyelonephritis (kidney infection).
The FDA has approved a five-day, once-daily IV and oral 750-mg regimen of levofloxacin drags (Levaquin, Ortho-McNeil, PriCara) for patients with complicated urinary tract infections (UTIs) and acute pyelonephritis (kidney infection).
The FDA has approved a five-day, once-daily IV and oral 750-mg regimen of generic levofloxacin (Levaquin drags, Ortho-McNeil, PriCara) for patients with complicated urinary tract infections (UTIs) and acute pyelonephritis (kidney infection).
